SCHEMBL22288935

SCHEMBL22288935

CC(C)c1nnc(S(=O)(=O)CCC(F)=C(F)F)s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.35
KMT2A Q03164 2/20 0.34
GLA P06280 1/20 0.33
TSHR P16473 1/20 0.33
ALDH1A1 P00352 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
LMNA P02545 3/20 0.32
KDM4E B2RXH2 1/20 0.32
S1PR4 O95977 1/20 0.32
HPGD P15428 1/20 0.32
S1PR1 P21453 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MEN1 O00255 1/20 0.32
APOBEC3G Q9HC16 1/20 0.31
GAA P10253 1/20 0.31
RXFP1 Q9HBX9 1/20 0.30
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20506736 0.80 HSD11B1 (0.43) MAPTSMN1; SMN2LMNA
SCHEMBL7022748 0.78 KMT2A (0.33) KMT2AALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL20506747 0.77 MAPT (0.37) MAPTSMN1; SMN2LMNA
SCHEMBL22583810 0.69 MAPT (0.32) MAPT
SCHEMBL20158613 0.68 CA1 (0.44) KMT2AALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL22577375 0.68 FDPS (0.35) MAPTSMN1; SMN2LMNA
SCHEMBL22576970 0.67 MAPT (0.32) MAPTSMN1; SMN2LMNA
SCHEMBL18291999 0.67 CA2 (0.52) KMT2ASMN1; SMN2MEN1
SCHEMBL22577104 0.66 ALDH1A1 (0.33) MAPTALDH1A1
SCHEMBL174908 0.66 MAPT (0.33) MAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144259-A1 CRYSTAL OF 2-(5-CYCLOPROPYL-3-(ETHYLSULFONYL)PYRIDIN-2-YL)-5-((TRIFLUOROMETHYL)SULFINYL)BENZO[D]OXAZOLE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-05-28 US disclosed
US-20260144258-A1 CRYSTAL OF 2-(5-CYCLOPROPYL-3-(ETHYLSULFONYL)PYRIDIN-2-YL)-5-((TRIFLUOROMETHYL)SULFONYL)BENZO[D]OXAZOLE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-05-28 US disclosed
EP-4748828-A1 METHYLENEBISBIPHENYL COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2026-05-27 EP disclosed
EP-4748825-A1 ACRYLIC ACID DERIVATIVE AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2026-05-27 EP disclosed
EP-4748826-A1 BIPHENYL COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2026-05-27 EP disclosed
EP-4748827-A1 DIMETHYLPENTA-2-ENEDIOATE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2026-05-27 EP disclosed
US-20260101898-A1 SULFONAMIDE COMPOUND AND HARMFUL-ARTHROPOD CONTROLLING COMPOSITION CONTAINING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-04-16 US disclosed
US-20260101899-A1 SULFONAMIDE COMPOUND AND HARMFUL-ARTHROPOD CONTROLLING COMPOSITION CONTAINING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-04-16 US disclosed
EP-4722205-A1 HETEROCYCLIC COMPOUND AND NOXIOUS ARTHROPOD-CONTROLLING COMPOSITION CONTAINING SAME Sumitomo Chemical Company, Limited (JP) 2026-04-08 EP disclosed
US-12577244-B2 Heterocyclic compound and harmful arthropod-controlling composition containing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-03-17 US disclosed
WO-2022004704-A1 METHOD FOR CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QoI FUNGICIDES 住友化学株式会社 2022-01-06 WO disclosed
EP-3917928-A1 THEOPHYLLINE DERIVATIVES WITH NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND RELATIVE USE ISAGRO S.p.A. (IT) 2021-12-08 EP disclosed
WO-2021215480-A1 PHENYL COMPOUND AND PLANT DISEASE CONTROL METHOD 住友化学株式会社 (JP) 2021-10-28 WO disclosed
WO-2021153794-A1 METHOD OF CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QOI FUNGICIDE 住友化学株式会社 2021-08-05 WO disclosed
WO-2021153782-A1 METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE 住友化学株式会社 2021-08-05 WO disclosed
WO-2021153786-A1 PHENYLACETIC ACID DERIVATIVE, USE THEREFOR, AND PRODUCTION INTERMEDIATE THEREOF 住友化学株式会社 2021-08-05 WO disclosed
WO-2021141106-A1 HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME 住友化学株式会社 2021-07-15 WO disclosed
WO-2021085263-A1 CRYSTAL OF 3-(DIFLUOROMETHYL)-1-METHYL-N-(1,1,3-TRIMETHYL-2,3-DIHYDRO-1H-INDEN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE 住友化学株式会社 2021-05-06 WO disclosed
WO-2020262648-A1 ACRYLIC ESTER DERIVATIVE, AND APPLICATION AND PRODUCTION INTERMEDIATE THEREOF 住友化学株式会社 2020-12-30 WO disclosed
WO-2020157668-A1 THEOPHYLLINE DERIVATIVES WITH NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND RELATIVE USE ISAGRO S.P.A. (IT) 2020-08-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577244-B2 Heterocyclic compound and harmful arthropod-controlling composition containing same CYC1, COX6C, CBR3 MAPT 4698/4885KMT2A 3397/4885GLA 2304/4885
US-20260144259-A1 CRYSTAL OF 2-(5-CYCLOPROPYL-3-(ETHYLSULFONYL)PYRIDIN-2-YL)-5-((TRIFLUOROMETHYL)SULFINYL)BENZO[D]OXAZOLE ATR, CCT4, CRY1 MAPT 2871/4885KMT2A 4674/4885GLA 1402/4885
US-20260101899-A1 SULFONAMIDE COMPOUND AND HARMFUL-ARTHROPOD CONTROLLING COMPOSITION CONTAINING SAME COX6B1, CYC1, COXFA4 MAPT 4871/4885KMT2A 3320/4885GLA 3426/4885
US-20260144258-A1 CRYSTAL OF 2-(5-CYCLOPROPYL-3-(ETHYLSULFONYL)PYRIDIN-2-YL)-5-((TRIFLUOROMETHYL)SULFONYL)BENZO[D]OXAZOLE PDXK, PUM1, CTRL MAPT 2059/4885KMT2A 4392/4885GLA 780/4885
US-20260101898-A1 SULFONAMIDE COMPOUND AND HARMFUL-ARTHROPOD CONTROLLING COMPOSITION CONTAINING SAME COX6B1, CYC1, COX6C MAPT 4881/4885KMT2A 3297/4885GLA 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.